Weight loss › Pallas Health
BalanzGM is reader-supported — we may earn a commission from links on this page, at no extra cost to you. See our affiliate disclosure. This article is information, not medical advice.
Short version. Pallas is the most compliance-conscious operator we have looked at in this category, and it is not close. They publish a public claims kit telling their own marketing partners what they may not say, they offer FDA-approved products alongside compounded ones, they prohibit paid search and brand bidding outright, and they require partner copy to be reviewed before publication. The caveat is that they are new — launched in 2026 — so there is little track record to weigh against the policy.
Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary.
Pallas at a glance
| What it is | A LegitScript-certified telehealth platform for medical weight loss, with a separate NAD+ programme |
| Medications | Semaglutide and tirzepatide, physician-supervised. Both FDA-approved products (Wegovy®, Ozempic®, Zepbound®, Mounjaro®) and compounded options |
| How you get it | 100% online consultations with licensed US providers; medication shipped to the patient |
| What counts as a conversion | Their own definition: the first paid order after a completed medical intake — explicitly “not leads or quiz completions” |
| Payment | Private pay only; no insurance |
| Differentiator | A free companion iOS app with dose, protein and symptom tracking and Apple Health sync, plus a stated clinical focus on preserving muscle during weight loss |
| Pricing | On the Pallas site. They state there are “no price increases ever” |
Who it suits
A reasonable fit if you…
- Want the choice between an FDA-approved product and a compounded one, made explicitly rather than by default
- Care that a provider polices what is said about it — they publish the rules and enforce copy review
- Want tracking and between-visit guidance rather than medication alone
- Want a provider whose stated clinical concern includes muscle preservation, not just the number on the scale
Look elsewhere if you…
- Want a long operating track record — they launched in 2026
- Need insurance billing; this is cash-pay only
- Are on Android — the companion app is iOS
- Live in a state outside their coverage; restrictions apply and we could not obtain the list
The thing that sets them apart
Pallas publishes an affiliate claims kit at a public URL. It is a document telling the people who promote them what they are forbidden from saying. Among the prohibitions:
- No describing compounded drugs as “equivalent to” or “the same as” the FDA-approved versions
- No applying clinical-trial data from brand-name drugs to compounded preparations
- No comparing tirzepatide and semaglutide results without dose context
- No before-and-after photos or weight-loss figures in any partner placement
- No guaranteed prescriptions or guaranteed outcomes
- No price comparisons against competitors
- No universal “no video call” claims — they note that some states require one
- No content targeting minors, pregnancy, or framed cosmetically
- No paid search and no brand bidding
- Partner copy submitted for review before publication
What Pallas prescribes
Weight management
NAD+ programme
On NAD+, their own required disclosure is worth quoting because of how restrained it is: “NAD+ (nicotinamide adenine dinucleotide) is a coenzyme; it is prescribed only when clinically appropriate by a US-licensed clinician. Compounded medications are prepared by US-licensed compounding pharmacies and are not FDA-approved.” No energy claims, no anti-ageing claims, no grouping it with peptide therapies. In a category where NAD+ is usually sold on exactly those promises, that is unusual.
What to know before you order
They are new
Pallas launched its programme in 2026. There is no long operating history, no accumulated body of independent customer feedback we could load, and no performance data we would treat as meaningful yet. A strong compliance posture is a good predictor, not a guarantee.
Cash pay only
Private pay, no insurance. They state pricing is transparent with no increases, which we could not independently verify beyond their saying so.
Compounded is still compounded
Offering FDA-approved products alongside compounded ones is a genuine advantage, but if you choose the compounded route the same facts apply as anywhere else — not FDA-approved, not reviewed for safety, effectiveness or quality. See compounded vs brand-name GLP-1, and note that the shortages that once justified compounding these molecules were declared resolved in 2025.
Who should not use it
How we rated Pallas
We do not test prescription services and we did not become a patient. This rating is based on our analysis of Pallas Health’s published programme information and their public affiliate claims kit, read in August 2026, alongside the FDA prescribing information for the molecules involved, following our review methodology. It reflects transparency, compliance posture and clarity of terms — not treatment outcomes, which we are in no position to judge.
What lifted it: FDA-approved products offered alongside compounded, LegitScript certification, a public claims kit that forbids the exact claims that mislead people, a refusal of paid search, mandatory copy review, and a conversion definition that excludes lead-generation gaming. What held it down: a short track record, no independent customer feedback we could verify, no published state list, and an iOS-only companion app.
Frequently asked questions
Can I get Wegovy or Zepbound through Pallas?
They state they offer both FDA-approved and compounded options. Confirm availability and pricing for the specific product on their site.
Is there a video consultation?
Consultations are 100% online. Pallas explicitly declines to claim that a video call is never required, noting that some states mandate one — which is the accurate position.
Does insurance cover it?
No. Private pay only.
What is the companion app?
A free iOS app with dose, protein and symptom tracking by photo or voice, Apple Health sync and guidance between visits.
Bottom line
Judged on the things a patient can actually check before handing over money — does this company offer the FDA-approved option, does it tell the truth about the compounded one, does it police what is said in its name, does it decline the marketing channels that invite abuse — Pallas comes out ahead of everything else we have examined in this category. The honest reservation is time: policy is cheap to publish and expensive to keep, and they have not yet had to keep it for long. Worth a look, with that in mind.
More in the weight loss hub: compounded vs brand-name · semaglutide vs tirzepatide
Medical disclaimer. This article is for general information only and is not medical advice. It is not intended to diagnose, treat, cure or prevent any condition. Prescription treatments require evaluation by a US-licensed clinician, who decides whether treatment is appropriate for you. Talk to your own healthcare provider before starting, stopping or changing any medication. Individual results vary.
